We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
NN Inc
NNBR
$311M
| $332K | ﹤0.01% |
63,164
-642
| -1% | -$3.86K |
|
|
IHC
2727
DELISTED
Independence Holding Company
IHC
| $332K | ﹤0.01% |
6,699
+123
| +2% | +$5.66K |
|
2728
Apyx Medical
APYX
$171M
| $330K | ﹤0.01% |
23,806
+1,714
| +8% | +$18K |
|
2729
CuriosityStream
CURI
$161M
| $330K | ﹤0.01% |
31,283
+1,225
| +4% | +$14.4K |
|
2730
Commercial Vehicle Group
CVGI
$147M
| $330K | ﹤0.01% |
34,881
+1,417
| +4% | +$13.4K |
|
|
GOCO
2731
DELISTED
GoHealth
GOCO
| $329K | ﹤0.01% |
4,359
+1,793
| +70% | +$190K |
|
|
TCRR
2732
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $329K | ﹤0.01% |
38,684
+1,435
| +4% | +$20.3K |
|
|
EMWP
2733
DELISTED
Eros Media World PLC
EMWP
| $329K | ﹤0.01% |
17,888
+721
| +4% | +$13.8K |
|
2734
Neurogene
NGNE
$712M
| $328K | ﹤0.01% |
2,267
-256
| -10% | -$39.2K |
|
2735
Park-Ohio Holdings
PKOH
$761M
| $328K | ﹤0.01% |
12,851
+247
| +2% | +$6.71K |
|
|
APPH
2736
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $327K | ﹤0.01% |
50,153
+11,694
| +30% | +$116K |
|
2737
Orrstown Financial Services
ORRF
$838M
| $326K | ﹤0.01% |
13,946
+25
| +0.2% | +$580 |
|
|
AKUS
2738
DELISTED
Akouos Inc
AKUS
| $323K | ﹤0.01% |
27,797
+694
| +3% | +$8.32K |
|
|
FLXN
2739
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $322K | ﹤0.01% |
52,824
+1,884
| +4% | +$11.7K |
|
2740
Autoliv
ALV
$9B
| $321K | ﹤0.01% |
3,744
-138
| -4% | -$12.7K |
|
2741
First Bank
FRBA
$454M
| $321K | ﹤0.01% |
22,780
+446
| +2% | +$5.95K |
|
2742
Ceco Environmental
CECO
$4.14B
| $319K | ﹤0.01% |
45,280
+416
| +0.9% | +$2.96K |
|
2743
Cardiff Oncology
CRDF
$77.2M
| $317K | ﹤0.01% |
47,650
+1,960
| +4% | +$12.3K |
|
2744
Korro Bio
KRRO
$195M
| $317K | ﹤0.01% |
897
+22
| +3% | +$8.66K |
|
2745
Latham Group
SWIM
$880M
| $317K | ﹤0.01% |
19,329
+1,100
| +6% | +$25.6K |
|
|
JNCE
2746
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $316K | ﹤0.01% |
42,573
+1,167
| +3% | +$7.23K |
|
|
USX
2747
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $315K | ﹤0.01% |
36,513
+1,585
| +5% | +$13.8K |
|
2748
SoundThinking
SSTI
$103M
| $313K | ﹤0.01% |
8,608
+400
| +5% | +$16.8K |
|
2749
Comscore
SCOR
$109M
| $312K | ﹤0.01% |
4,005
+242
| +6% | +$19.2K |
|
|
MCBC
2750
DELISTED
Macatawa Bank Corp
MCBC
| $312K | ﹤0.01% |
38,855
-610
| -2% | -$4.99K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.